# Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes

> **NCT02856581** · PHASE3 · TERMINATED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 23 (actual)

## Conditions studied

- Lung Carcinoma

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo
- **OTHER:** Tobacco Cessation Counseling

## Key facts

- **NCT ID:** NCT02856581
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-29
- **Primary completion:** 2021-05-28
- **Final completion:** 2022-04-15
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2022-07-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02856581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02856581, "Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02856581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*